# Rafael Holdings (stock symbol: RFL) Logo in transparent PNG and SVG formats

## Rafael Holdings Logo large

### Rafael Holdings Logo large Download PNG (34.1 KB)

![Rafael Holdings Logo large Download PNG (34.1 KB)](/img/orig/RFL_BIG-23080d8e.png)

### Rafael Holdings Logo large Download SVG (9.01 KB)

![Rafael Holdings Logo large Download SVG (9.01 KB)](/img/orig/RFL_BIG-436bf58d.svg)

## Rafael Holdings Logo icon format

### Rafael Holdings Logo icon format Download PNG (22.07 KB)

![Rafael Holdings Logo icon format Download PNG (22.07 KB)](/img/orig/RFL-934db6ab.png)

### Rafael Holdings Logo icon format Download SVG (9.82 KB)

![Rafael Holdings Logo icon format Download SVG (9.82 KB)](/img/orig/RFL-a73fc556.svg)

## Rafael Holdings Logo large for dark backgrounds

### Rafael Holdings Logo large for dark backgrounds Download PNG (34.21 KB)

![Rafael Holdings Logo large for dark backgrounds Download PNG (34.21 KB)](/img/orig/RFL_BIG.D-59d7ff65.png)

### Rafael Holdings Logo large for dark backgrounds Download SVG (9.01 KB)

![Rafael Holdings Logo large for dark backgrounds Download SVG (9.01 KB)](/img/orig/RFL_BIG.D-c4804d6e.svg)

## Rafael Holdings Logo icon format for dark backgrounds

### Rafael Holdings Logo icon format for dark backgrounds Download PNG (22.07 KB)

![Rafael Holdings Logo icon format for dark backgrounds Download PNG (22.07 KB)](/img/orig/RFL.D-d57957ea.png)

### Rafael Holdings Logo icon format for dark backgrounds Download SVG (9.82 KB)

![Rafael Holdings Logo icon format for dark backgrounds Download SVG (9.82 KB)](/img/orig/RFL.D-9e4eb39c.svg)

## About Rafael Holdings

Rafael Holdings, Inc. holds interests in clinical and early stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. The company operates in two segments, Pharmaceuticals and Real Estate. It engages in the leasing of a commercial office building, as well as an associated 800-car public garage; and development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. The company's lead drug candidate is CPI-613 (devimistat), which is being evaluated in various clinical studies, including two Phase III registrational clinical trials for the treatment of metastatic pancreatic cancer and r/r acute myeloid leukemia. Rafael Holdings, Inc. is headquartered in Newark, New Jersey.

1. Website domain: rafaelholdings.com
2. Employees: 51
3. Marketcap: $51.05 Million USD


## Categories
- [x] ðŸ‡ºðŸ‡¸ United States
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
